Category Archives: Business and Investments

Latest From Business and Investments

AAAS Trains Student Scientists in the Art of Science Communication

newspaper

Rahman A. Culver, project director, American Association for the Advancement of Science From grant writing to interaction with their community, today’s young scientists must also be able science communicators. The American Association for the Advancement of Science (AAAS) Mass Media Science & Engineering Fellowship seeks to increase communication skills in student scientists. The lessons they learn through the fellowship experience will benefit their career path and help them increase public understanding of science and technology. Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , ,

Biotech is a Cornerstone of New Orleans’ Economic Renaissance

New Orleans BioInnovation Center

New Orleans shows the signs of a city reborn from the destruction brought on by Hurricane Katrina.  The changes in the city’s infrastructure and building projects have certainly been among them.  The Crescent City reached a milestone in its renaissance last June when the New Orleans BioInnovation Center opened for business. The center is a 65,000-square foot biotech business incubator created to foster entrepreneurship within the New Orleans bioscience community and help commercialize technologies developed at Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , , ,

Where’s the Deal?

2011-drug-deals-thumb

With only two weeks to go in 2011 it is looking like a five year low for deals. The chart below shows therapeutic deals dropping every year since 2007. We use the Windhover/Elsevier Strategic Transaction Database as our starting point for deal analytics. We analyze each deal to determine if the deal is for a drug asset, removing generic/OTC deals, manufacturing/service deals, device/diagnostics/tools deals, and tech transfer deals. What remains are deals for biotech company Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , , ,

BIO CEO Company Snapshot: NuPathe Inc.

NuPathe

The Company Snapshots have returned for our next One-on-One Partnering event, the BIO CEO & Investor Conference, taking place in New York City this February.  The companies that will be profiled in these snapshots will all be presenting at the event, and we hope this provides the opportunity to learn more about them, and catch up on what’s new. For our first Snapshot for the BIO CEO event, we’ve spoken with NuPathe Inc. about their Read More >

The One-on-One Compass  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , ,

Drug Discovery & Development: Partnering for Success…and Survival

There are pressures on Big Pharma and biotech emerging companies alike to engage in more creative deal making to ensure positive outcomes for both parties, Ted Agres writes in Drug Discovery and Development. While the number of deals has remained relatively flat in 2011, the dollar amount of individual deals has increased overall. Oncology remains the most sought after category, followed by CNS, anti-infectives, metabolic diseases, dermatology and cardiovascular. Partnering activity at BIO events is on Read More >

Business of Biotech  |  Leave a comment  |  Email This Post
Tags: , ,